Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» If AbbVie Discounts its Hep C Drug, Would Pricing Reach a Tipping Point?
If AbbVie Discounts its Hep C Drug, Would Pricing Reach a Tipping Point?
If AbbVie Discounts its Hep C Drug, Would Pricing Reach a Tipping Point?
Submitted by
admin
on October 14, 2014 - 9:51am
Source:
WSJ Pharmalot
News Tags:
AbbVie
drug pricing
hepatitis C
Gilead Sciences
Headline:
If AbbVie Discounts its Hep C Drug, Would Pricing Reach a Tipping Point?
Do Not Allow Advertisers to Use My Personal information
